Cart
sales@molnova.com
NVS-ZP7-4
CAS No. 2349367-89-9
NVS-ZP7-4 ( —— )
Catalog No. M24067 CAS No. 2349367-89-9
NVS-ZP7-4 is a inhibitor of Zinc transporter SLC39A7 (ZIP7).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 85 | In Stock |
|
| 5MG | 143 | In Stock |
|
| 10MG | 267 | In Stock |
|
| 25MG | 537 | In Stock |
|
| 50MG | 767 | In Stock |
|
| 100MG | 1053 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameNVS-ZP7-4
-
NoteResearch use only, not for human use.
-
Brief DescriptionNVS-ZP7-4 is a inhibitor of Zinc transporter SLC39A7 (ZIP7).
-
DescriptionNVS-ZP7-4 is a inhibitor of Zinc transporter SLC39A7 (ZIP7).
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorZinc transporter SLC39A7 (ZIP7)
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2349367-89-9
-
Formula Weight501.6
-
Molecular FormulaC28H28FN5OS
-
Purity>98% (HPLC)
-
SolubilityDMSO:120mg/mL (239.22 mM)
-
SMILESO=C(NC12CCN(C[C@H](Cc3ccccc3)Nc3nc(ccc(F)c4)c4s3)CC2)Nc2c1cccc2
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Nolin E, et al. Discovery of a ZIP7 inhibitor from a Notch pathway screen. Nat Chem Biol. 2019 Feb;15(2):179-188.
molnova catalog
related products
-
X-press Tag Peptide
X-press Tag is an N-terminal leader peptide; this N-terminal peptide contains a polyhistidine sequence, the Xpress epitope (part of bacteriophage T7 gene 10 protein) and an enterokinase cleavage site. Anti-Xpress antibodies recognize the Xpress epitope sequence found in this leader peptide.
-
SI 60
Sanaid SI 60 is an aromatic sulfonium salt and is initiator for thermosetting polymerization at low temperature.
-
Isorhamnetin 3-O-gal...
Isorhamnetin 3-O-galactoside shows antioxidant, anti-inflammatory, neuroprotective,and barrier protective activities, it could be used as a candidate therapeutic for treatment of severe vascular inflammatory diseases.
